Nicholas Jason Singer 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-20 4:30 pm Purchase | 2022-12-02 | 13D | Eterna Therapeutics Inc. BTX | Nicholas Jason Singer | 393,766 7.670% | 289,016 (+275.91%) | Filing |
| 2022-02-16 5:15 pm Sale | 2021-12-31 | 13G | Eterna Therapeutics Inc. BTX | Nicholas Jason Singer | 104,750 4.000% | -84,849 (-44.75%) | Filing |
| 2021-04-30 4:05 pm Purchase | 2021-03-25 | 13G | Eterna Therapeutics Inc. BTX | Nicholas Jason Singer | 189,599 9.130% | 189,599 (New Position) | Filing |